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Turmeric / Oregano Extracts as Wound Healing Agents in a Diabetic
Animal Model

ABSTRACT
Diabetic wound infections and pressure ulcers pose a significant challenge to healthcare
providers worldwide. With an increased incidence of chronic skin ulcers and a
significant financial impact on healthcare systems, reaching $25 billion annually, new
methods to treat chronic and diabetic ulcers are in great need. The current study
provides new and innovative wound care products that reduce inflammation, clear
infection and improve healing time in an animal model of pressure and diabetic ulcers.
Animal model with excisional wound & pressure ulcer was done on the dorsal side of
the rats in diabetic and non-diabetic groups. Our results showed that pressure ulcer had
significantly different pathological features compared to excisional wounds. Diabetes
caused skin changes that negatively affects the healing process.
Different turmeric extracts, oregano essential oil and chitosan nanoparticles
were tested for their antibacterial & antioxidant activity. Results showed that turmeric
ethanolic extract 5%, oregano essential oil 1% & chitosan nanoparticles 1% had the
most antibacterial & antioxidant effects. Ointments were synthesized of each herb
individually. An in vivo pilot study was conducted on diabetic and non-diabetic rats
with pressure ulcer. Results showed that turmeric 5% ointment successfully healed the
ulcer in both diabetic and non-diabetic rats by day 15. The oregano 1% ointment
achieved complete healing by day 15 in the non-diabetic group while in the diabetic
group was achieved by day 21.
The above concentrations were incorporated in different forms (ointment,
amorphous hydrogel & nanofibers). Those forms were tested for their antibacterial,
cytotoxic effect & in vivo using Tegadermâ (commercial wound dressing) as positive
control. Our results showed that the designed formulas had significant antibacterial
effect as Tegadermâ. On testing the formulations on mouse fibroblast cell line (L929),
ointment & hydrogel were non-cytotoxic while nanofibers showed relative cytotoxicity
if compared to Tegadermâ that was highly toxic. By testing the formulations in vivo,
our results showed that by day 15 ointment and nanofibers achieved complete wound
closure while hydrogel and Tegadermâ did not.
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Chapter 1 : Literature Review
1.1 Introduction
Chronic wounds such as diabetic foot infections and pressure ulcers, pose a significant
challenge to healthcare providers worldwide. Over the past years, the incidence of
chronic skin ulcers dramatically increased, leading to a huge financial impact on
healthcare systems, reaching $25 billion annually in the United States (Gainza et al.,
2015; Han & Ceilley, 2017). Skin ulcers cause high morbidity and mortality rates. A
study conducted in 2011 showed the mortality rate in 2 years follow up of skin ulcer
patients reached 28% due to chronic skin complications (Escandon et al., 2011).
Diabetes is one of the leading causes for skin infection and chronic ulcers. With
the prevalence of diabetes increasing worldwide new wound care products are needed
to reduce healing time and improve patients’ quality of life (Jhamb et al., 2016).
In the present study, we describe new and innovative wound care product that
reduce inflammation, clear infection and reduce healing time in an animal model of
diabetic ulcer. The current model improves the understanding of the healing process
under different conditions. Using readily available rodents, with low cost and the ability
to use a relatively large number of animals, making research more appropriate and
reducing statistical errors (Trujillo et al., 2015; Trostrup et al., 2016). The present model
avoids the wound contracture characteristic of rodents by compromising the
subcutaneous muscle (panniculus carnosus), therefore, making the wound more
clinically relevant to human studies (Wong et al., 2011; Seaton et al., 2015).

1.2 Global Impact
Chronic ulcers have negative impact on patients, their families, healthcare systems and
economies as well. They negatively affect patients’ quality of life, as well as, daily
lifestyle and job performance (Herber et al., 2007).
Ulcer management is a costly process reaching £5,000 per patient annually (Kapp
et al.,2017 ; Guest et al., 2016). Chronic skin ulcers also affect patients’ productivity
leading to an economic impact, besides the huge healthcare expenditure, reaching US
$25 billion annually (Rahman et al., 2010; Han et al., 2017).
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1.3 Healing process in acute and chronic wounds
The normal healing process of the skin is characterized by the following phases:
coagulation, acute inflammation, proliferation and remodeling (Khodaeian et al., 2015).
Following acute injury circulating platelets are exposed to collagen leading to
the activation of coagulation cascade, where fibrinogen is converted to fibrin leading
to thrombus clot formation (Gilbert et al, 2016). This clot is crucial in protecting the
wound from infection, as well as preventing further blood loss (Bielefeld et al., 2013).
Activated platelets release pro-inflammatory cytokines and growth factors that recruit
inflammatory cells to the site of wound to initiate the inflammatory phase (Gilbert et
al., 2016; Hameedaldeen et al., 2014).
In the inflammatory phase, neutrophils and macrophages are the key players.
Neutrophils remove bacteria, foreign objects from the wound, produce proteolytic
enzymes such as matrix metalloproteinase (MMP) that break down dead tissue
(Hameedaldeen et al., 2014). Monocytes later differentiate to macrophages that
phagocytose foreign organisms and dead neutrophils. They also release transforming
growth factor beta (TGF-ß) and other cytokines, and thereby enhance fibroblasts and
epithelial cells movement into the wound area (Bielefeld et al., 2013; Hameedaldeen
et al., 2014).
The proliferation phase overlaps with the inflammatory phase, and is primarily
characterized by three major events: angiogenesis; extracellular matrix (ECM)
synthesis and re-epithelialization (Gilbert et al., 2016; Emanuelli et al, 2016). In the
proliferative phase, macrophages shift to an anti- inflammatory phenotype expressing
different anti-inflammatory mediators, proteases and protease inhibitors, and growth
factors, such as vascular endothelial growth factor (VEGF) and TGF- ß that encourage
cell proliferation and protein synthesis. Endothelial cells and fibroblasts then
accumulate in the wound site encouraging occurrence of angiogenesis and fibroplasia,
providing oxygen, nutrients, for the proliferating cells to form granulation tissue
(Tsourdi et al.,2013).
The remodeling phase is considered the last step of tissue remodeling leading
to skin recovery. During the remodeling phase, immature ECM and collagen type III
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are degraded by MMPs and replaced with collagen I (Zhao et al., 2016; Gilbert et al.,
2016; Bielefeld et al., 2013). Subsequently, collagen fibers rearrange they lie closer
together across tension lines, facilitating cross-linking and thus increases the tensile
strength of the wound where unnecessary blood vessels and cells undergo apoptosis
and replaced by normal skin tissue (Emanuelli et al., 2016; Baltzis et al., 2014) (Figure
1.A).
In chronic skin ulcers, reactive oxygen species (ROS) are the key players.
Elevated levels of ROS cause oxidative damage in DNA, proteins and lipids leading to
tissue damage (Donato-Trancoso et al., 2016). They induce inflammation, which in turn
lead to epithelial dysfunction, decreased reperfusion, impaired angiogenesis resulting
in poor ulcer healing (Blakytny et al., 2006). Also chronic skin ulcer is characterized
by reduced levels of tissue inhibitors of MMPs (TIMPs), the proteins that inhibit MMPs
activity and as a result elevated levels of matrix metalloproteinases accelerates tissue
degradation (Baltzis et al., 2014; Amin et al., 2016). MMPs degrade the growth factors
involved in the healing process as insulin growth factor (IGF-I), TGF- β1, and platelet
derived growth factor (PDGF) which are crucial for the healing process, thus inhibiting
ECM & re-epithelization (Falanga, 2005). High concentrations of ROS and low TGFβ1 expression level increases macrophage chemo attractant protein-1 (MCP-1) levels,
which in turn attract greater numbers of macrophage leading to sustained inflammation
(Blakytny et al., 2009). Impaired angiogenesis is seen in patients with chronic ulcers.
An angiogenesis-promoting growth factor, hypoxia inducible factor-1α (HIF-1α) is
induced in response to hypoxia resulting in the transcription of growth factors as VEGF
which is important for angiogenesis. In chronic ulcers, HIF-1α is down regulated
leading to low expression of VEGF as a result poor angiogenesis and impaired wound
healing (Catrina et al., 2004) (Figure 1.B).
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Figure 1 Overview for Mechanism of Healing in Acute and Chronic Wounds
A. Acute Wound. After acute injury circulating platelets are exposed to collagen
leading to the activation of coagulation cascade, where fibrinogen is converted to
fibrin leading to the formation of thrombus. Activated platelets produce proinflammatory cytokines and growth factors that employ inflammatory cells to the
wound site to initiate the inflammatory, proliferative & remodeling phases. B.
Chronic Wound is characterized by hyper inflammation where elevated levels of
inflammatory cytokines as TNF alpha and IL-1 lead to inhibition of antiinflammatory macrophages. Also, in chronic wounds, MMPs are elevated and
reduced levels of TIMPs accelerate ECM and growth factors degradation all this
leads to impaired healing process. Adapted from (Larouche et al., 2018).

1.4 Types of Chronic wounds
Chronic skin ulcers have a complex etiology, with a diverse range of
comorbidities making it difficult to study and find a therapeutic agent. Most chronic
wounds fall into four main categories: arterial, venous, pressure, and diabetic ulcers
(Figure 2). In the current study we will focus mainly on pressure ulcers in diabetes
mellitus (DM).
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Figure 2 Common Causes of Chronic Wounds
Diabetic and Pressure Ulcers showed to be the most prevalent types of ulcers among
all chronic wounds adapted from (Iyun et al, 2016).
1.4.1 Diabetic Ulcers
Diabetic Ulcers and foot infections are major complications affecting 15–20 % of
diabetic patients’ worldwide (Emanuelli et al., 2016; Jhamb et al., 2016). According to
the International Diabetes Federation, in 2015 diabetes affected 415 million patients,
with an expected increase 642 million by 2040 (Ogurtsova et al., 2017). Diabetic foot
management costs nearly 9-13 billion USD annually on top of the management of DM
itself (Raghav et al., 2018). Foot disorders include ulceration, infection and gangrene
which are the main causes of hospitalization and in severe cases might lead to further
disability due to amputation (Ray et al., 2005; Jhamb et al., 2016).
Hyperglycemia and peripheral neuropathy with impaired circulation, increase
the risk of ulceration (Popov, 2010; Zhao, et. al., 2016). Moreover, diabetes related
metabolic complications directly disrupt wound healing process (Baltzis et. al., 2014).
The accumulation of advanced glycation end-products (AGEs) stimulates oxidative
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stress, and disrupts the normal inflammatory cell function. Poor circulation and poor
oxygenation are contributing factors to poor healing and chronicity of the wounds in
diabetic patients (Berlanga-Acosta et al., 2013).
1.4.2 Pressure Ulcers (PU)
Pressure ulcers (Bed sores), also known decubitus ulcers, are the most common
example of tissue necrosis (Roaf, 2006). Most pressure ulcers develop mainly in
elderly bedridden patients (70%), following strokes, major orthopedic, and spinal cord
injuries (Tubaishat et al., 2018; Grey et al., 2006). According to the Agency for
Healthcare Research and Quality's (AHRQ) pressure ulcer affect 2.5 million patients
per year in the US and cost $9.1-$11.6 billion per year. Skin surface over the bony
prominences (e.g., hips, ankles, heels, coccyx, scapulae) are the most vulnerable areas
(Baron et al., 2016 ; Mendoza-Garcia et al., 2015) (Figure 3). Those ulcers are painful
and prone to infection, which may result sepsis or osteomyelitis (Mendoza-Mari Y et
al., 2013). There are four main factors that are involved in pathogenesis of pressure
ulcer which are; pressure, shear, friction, and moisture (Grey et al., 2006). Due to
continuous pressure the blood supply to the skin is obstructed leading to poor
circulation resulting in tissue death and an ulcer development (Figure 4).
According to the National Pressure Ulcer Advisory Panel (NPUAP), pressure
ulcers are classified into 4 stages; stage 1: regions of intact skin with non-blanchable
erythema. Stage 2: partial-thickness skin loss with exposed dermis, with pink to red
viable wound area, and deeper tissues are not visible. Stage 3: full-thickness skin loss
with adipose tissue seen in the ulcer. Stage 4: full-thickness skin and tissue loss with
exposed muscle, tendon, ligament, cartilage or bone in the ulcer (The National Pressure
Ulcer Advisory Panel -, European Pressure Ulcer Advisory Panel, and Pan-Pacific
Pressure Injury Alliance, 2014) (Figure 5).
In the early stages, the patient has an intact nervous system, so the pressure is
painful (stages 1 and 2), Once the epithelium is destroyed the ulcer may be relatively
painless and can progress rapidly (stages 3 and 4) (Grey et al., 2006). The prevalence
of high-grade pressure ulcers (grades 3 and 4) may reach 4% in elderly persons (Anders
et al., 2010). Pressure ulcers may be prevented by changing patient position frequently
(Nageswaran et al., 2015).
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Figure 3 Common sites of pressure ulcer
Figure showing most bony prominences where skin ulcers most likely occur adapted
from (Grey et al., 2006).
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Figure 4 Pathophysiology of Pressure Ulcer
Diagram showing pathophysiology of pressure ulcer, sustained pressure leads to
decrease of blood flow, resulting in ischemia and fluid escapes to extravascular spaces
leading to edema and tissue death adapted from (Grey et al., 2006).
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Figure 5 Stages of Pressure Ulcer
Stages of Pressure Ulcers according to NPUAP where; Stage 1 Show intact skin nonblanchable erythema. Stage 2 Partial-thickness skin loss with exposed dermis. Stage 3 Fullthickness skin loss with exposed adipose tissue. Stage 4 Full-thickness skin and tissue loss
with exposed muscles, tendons. Adapted from (http://smart.servier.com/) with modifications.

1.4.3 Other types of Ulcers
Venous Leg Ulcer arise from chronic venous insufficiency in the lower limbs (Guest
et al., 2018; Comerota et al., 2015). It causes a local rise in blood pressure, leading to
leakage of macromolecules and red blood cells into the perivascular space. Subsequent
edema and fibrosis decrease growth factors and oxygen diffusion, therefore, causing
tissue ischemia (Guenin-Macé et al., 2014; Morton & Phillips, 2016).
Arterial Ulcers are less common than venous and diabetic ulcers, they occur
because of arterial insufficiency and poor perfusion, leading to insufficient skin
oxygenation, and tissue breakdown (Guenin-Macé et al., 2014).
Other types of skin ulceration include trauma, burn, and immune dysfunction,
(Guenin-Macé et al., 2014; Tomioka et al., 2018).
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1.5 Skin Ulcer Management
Skin ulcer management and prevention remain a challenge for healthcare (Sibbald et
al., 2012). Preventive actions include; risk assessment, patient mobility and nutrition,
skin care and regular pressure redistribution (Langemo et al., 2015). Once the skin is
damaged action plans should take place, these might include;
1.5.1 Debridement
Debridement and removal of necrotic tissues to clean the wound and decrease infection
(Leaper et al., 2011; Burtis et al., 2009).This can be achieved by surgical/ mechanical,
or biological methods (Woo et al., 2015; Falabella, 2006). Biological debridement
involve enzymes, although it may cause inflammation and slowing of the healing
process (Falabella, 2006). Surgical or mechanical debridement are non-selective, and
remove viable as well as necrotic tissues (Falabella, 2006). Other types of debridement,
include Maggot debridement which involves larvae to remove only necrotic tissues
(Sherman, 2009).
1.5.2 Antimicrobials
Antiseptics and topical or systemic antibiotics are the first line of treatment of skin
ulcers to prevent infection, choice of antibiotic line should depend on culture and
sensitivity results (Norman et al., 2016; Tsourdi et al., 2013). Extensive use of
antibiotics in developing countries leads to antimicrobial resistance, and increases the
risk of more dangerous types and resistant infections (Ayukekbong et al., 2017).
1.5.3 Topical preparations and Wound Dressings
Topical Preparations: including antimicrobials, antioxidants, growth factors and
analgesics are used for wound care (S. Gupta et al.,2017). Although, easy to prepare
and low cost, there are not convenient due to the need for multiple applications, and
wound cover or dressing to protect the wound surface (Lipsky et al., 2009).
Wound Dressings have been developed to protect the wounds and accelerate
healing (Han et al., 2017). Choice of dressing depends on the type and location of the
wound and the quantity of exudates (S. Gupta et al., 2017). The table below shows
examples of commercially available dressings with their advantages and disadvantages
(Table 1)
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Table 1: Examples of commercially available dressings used in wound treatment
Dressing
Type

Commercial
Examples

Gauze

Vaseline Gauze

Comments

•
•
•
•

Inexpensive.
Cause drying.
May cause further damage on changing.
Need to be changed frequently.
Occlusive & Retains moisture.
For non-exudative wounds as it doesn’t
absorb exudates.
Protect against bacteria.
Inexpensive.
Can be amorphous or sheets.
Permeable to Oxygen.
Protect from bacteria.
Have low tendency to absorb exudates.
Useful for dry wounds.
Help in autolytic debridement.

Films

Bioclusive ®
Blisterfilm®
Tegaderm®

•
•

Hydrogels

Nu-gel®
Kikgel®
Aqua-gel®
Aquaform®

•
•
•
•
•
•
•

®

Hydrocolloids

Aquacel
DuoDERM®
Tegasorb®

Foams

3M Adhesive
Foam®
Lyofoam®

•
•
•
•
•
•
•

Hydro fibers

Aquacel®

•
•
•
•

Alginates

Algisite®
Kaltostat®

•
•
•
•
•

•
•

Used for dry wound.
Occlusive, not used with exudative
wound.
Not for infected wounds.
Synthetic polymers made of
polyurethane (May cause allergy) and
silicone.
They have absorptive capacity.
Protect against bacteria.
They minimize trauma during dressing
changes.
Made of sodium carboxymethyl
cellulose (CMC).
Have high tendency to absorb exudates.
Used for infected wounds.
They are inert dressing don’t involve in
the healing process.
Expensive Dressings.
Do not adhere to the wound.
Highly absorbent.
Hemostatic.
Some patients may feel burning
sensation this can be due to the rapid
movement of fluid from wound into the
dressing.
It doesn’t protect against bacteria.
Not suitable for dry wounds.

References

(Han et al.,
2017)
(S. Gupta et al.,
2017.)
(Han et al.,
2017)

(S. Gupta et al.,
2017.)
(Health Quality
Ontario, 2009)
(Sweeney et al.,
2012)
(Boatenget al.,
2015)
(Han et al.,
2017)
(Sweeney et al.,
2012)
(Han et al.,
2017)
(Sweeney et al.,
2012)

(Sweeney et al.,
2012)
(Han et al.,
2017)

(Han et al.,
2017)
(Sweeney et al.,
2012)
(Health Quality
Ontario, 2009)
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1.5.4 Skin Grafts & Substitutes
Autologous, full or partial thickness skin grafts have been used for non-healing chronic
wounds (Han et al., 2017; Serena et al., 2015).
Recently, tissue-engineered skin substitutes gained importance due to their
advantages, such as biodegradability, and their promotion of tissues growth, therefore,
increasing healing rate and improving patient care (Boateng et al., 2015; Maarof et al.,
2016). Some of those substitutes include; Omnigraft accelerates healing in diabetic foot
and burns (Han et al., 2017). The main disadvantage of these scaffolds is their high cost
(Han et al., 2017).
1.5.5 Growth Factors
Growth factors, such as, PDGF, fibroblast growth factor (FGF) and epidermal growth
factor (EGF), are promising therapeutic agents in wound healing (Loh et al., 2013).
Several forms of growth factors have been studied in different types of chronic skin
ulcers, with variable success, in addition to, their low bioavailability (Barrientos et al.,
2014; Sweeney et al., 2012).
1.5.6 Vacuum Assisted Closure (VAC)
Vacuum Assisted Closure (VAC), or negative pressure is an effective, noninvasive
adjunctive therapy that has been in use since 1997 to accelerate chronic skin ulcer
healing (Han et al., 2017; Nain et al., 2011). Vacuum increases blood flow, enhances
oxygenation, cellular growth and tissue repair (Schreiber, 2016), as well as enhancing
wound contraction (Huang et al., 2014).
These devices limit the patients’ mobility and are noisy. Changing the dressing and
tube is usually painful and cause bleeding. VAC devices are also not recommended for
cancer patients, spinal cord injuries or patients on anticoagulants (Schreiber, 2016).
1.5.7 Hyperbaric Oxygen therapy (HBOT)
High pressure aims to increase the oxygen concentration in the patient’s blood and
therefore, improving the oxygen supply to the wound. Although HBOT showed
improvement in wound healing, there are still some doubts, and the high oxygen
pressure may be harmful to the brain (Tuk et al., 2014; Van Neck et al., 2017; Han et
al., 2017).
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1.6 Phytomedicine in treatment of skin ulcers
Natural medicinal plant extracts have been widely used as topical applications for
wound healing. Aloe vera, Echinacea , Chamomile, Ginseng, Ginkgo, Green tea and
olive oil, as well as, many other plants were found to be effective in wound healing
(Pazyar et al., 2014). Several research groups across the world showed that
phytochemicals available in natural herbs might help in treating inflammatory
conditions and might aid in wound healing and skin regeneration (Thangapazham et al.,
2016). Phytochemicals protect the skin by suppressing free radicals and inhibition of
nuclear factor kappa B (NF-κB) leading to reducing inflammation. Phytochemicals also
affect other signaling pathways, including transforming growth factor-beta (TGF-β).
Extensive research is needed to clarify the molecular targets and mechanisms of
phytochemicals will lead to the development of effective formulations (Shah & AminiNik, 2017). In the current study, we will discuss how turmeric extract and oregano
essential oil will help in wound healing.
Turmeric (the golden spice), is derived from the rhizome of Curcuma longa.
Turmeric has shown antioxidant, anti-inflammatory, anticancer, antidepressant, antiaging, antidiabetic, antimicrobial, wound healing effect (Figure 6) (S. C. Gupta et al.,
2012). The main component of turmeric is curcumin, which was thought to be
responsible for all biological activities. Recent studies identified new compounds other
than curcumin. It became unclear that those activities are through curcumin or due to
other compounds or synergistically of both. Those compounds showed to have antiinflammatory and anticancer effect (Figure 7) (Aggarwal et al., 2013).
Curcumin was found to be effective in wound healing in diabetic and nondiabetic animal models and in animals subjected to γ-radiation (Jagetia et al., 2004)
(Mani et al., 2008). Phan et al. (2001), showed that curcumin has inhibitory activity
against hydrogen peroxide-induced oxidative damage in human keratinocytes and
fibroblasts. Cheppudira et al. (2013), showed that curcumin could be a potential
natural therapy to control severe pain associated with burn.
Turmeric contain different proteases that might aid in stopping bleeding
(Shivalingu et al., 2015). Sarafian et al. (2015), proposed that turmeric micro-emulgel
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may be considered a therapeutic option for many patients suffering from plaque
psoriasis. Other research showed that turmeric extracts has a potential therapeutic role
in spinal cord injuries (Kamel et al., 2017). Meizarini et al. (2018), showed that wound
dressing consisting of a combination of zinc oxide and turmeric extract proved to be
effective as an anti-inflammatory. Lone et al. (2018), showed that turmeric extract
accelerated healing of dry socket alveolar osteitis following tooth extraction.

Figure 6 Medicinal Uses of Turmeric
Turmeric was found to be helpful in treatment of chronic diseases, such as psoriasis,
inflammatory diseases as inflammatory bowel disease, and also proved to be helpful in
wound healing adapted from (Aggarwal et al., 2007). Its low toxicity and side effects
and its availability in large quantities in cheap prices make it a suitable therapeutic
agent.
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Curcumin has anti-inflammatory and anti-oxidative properties therefore, it may
affect many molecular targets involved in inflammation, oxidative stress. It inhibits
arachidonic acid metabolism, and downregulate enzymes as lipoxygenase (LOX),
cyclooxygenase 2 (COX2) and inducible nitric oxide synthase (iNOS). As a result, it
blocks the synthesis of prostaglandin (PG), and cytokines, e.g. interleukin (IL), and
tumor necrosis factor (TNF). Curcumin also promotes the release of steroidal hormones
from the adrenals. Further studies are needed to reveal the molecular targets of different
Turmeric extract components (Figure 8) (Rao et al., 2007).

Figure 7 Non- Curcumin Components of Turmeric
Turmeric has a range of constituents other than curcumin that exert anti-inflammatory
effect and thus help in wound healing adapted from (Aggarwal et al., 2013).
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Figure 8 Anti-inflammatory & Anti-oxidant Mechanism of Curcumin
Curcumin suppresses inhibitory unit Ik-Bα, which hinders subsequent nuclear
translocation of the functionally active subunit of NF-kB, inhibiting the inducible nitric
oxide synthase (iNOS) as a result inhibit nitric oxide leading to decreased expression
of cyclooxygenase 2 (COX2) suppressing inflammation. Curcumin also inhibits
lipoxygenases (LOX) resulting in suppressing leukotriene, which are inflammatory
mediators. Adapted from (Rao et al., 2007).
Oregano is essential oil obtained from leaves of Origanum vulgare family
Lamiaceae (Olmedo et al.,2014). The main components of oregano are the phenols
isomers carvacrol and thymol, as well as their precursor monoterpenes γ-terpinene and
p-cymene (Sakkas et al., 2017). Oregano shows antimicrobial, antifungal, antiinflammatory and antioxidant effects (Ragi et al., 2011; Chun et al., 2005; Rosato et
al., 2009). The antimicrobial effect was found to be at concentration less than 2%
(Boateng et al., 2015).

1.7

Nanomaterial in Wound Care

Nanomaterial reduce drug toxicity, enhance solubility of hydrophobic drugs, increase
drug penetration, provide controlled release of the drugs, increase their stability and
protect them from being degraded (Goyal et al., 2016 ; Wang et al., 2011).
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Nanofibers are considered one of the dressings that offer great advantages over
current dressings. Electrospun nanofibers possess high surface area, porosity and have
structure that mimic the ECM (Chen et al., 2017). Current research focuses on reducing
inflammation and infection, therefore, creating positive environment for wound healing
(Chen et al., 2017). Recent uses of nanofibers for wound healing include; loading
growth factors to promote angiogenesis and accelerate wound healing rate, polyanilinechitosan nanofibers to enhance cell attachment and proliferation, silver nanoparticles
(AgNPs) incorporated in collagen nanofibers to decrease wound infection rates and
accelerated closure (Moutsatsou et al., 2017; Rath et al., 2016; Xie et al., 2013).
Nanoparticles used for wound-healing applications are often made of polymers
that have been used previously as wound dressings (Kalashnikova et al., 2015).
According to literature there are different means for nanoparticles absorption through
skin (Figure 9) (Palmer et al., 2016).
Chitosan is considered one of the most widely used biopolymers for
nanoparticles preparation. This is due to its biodegradability, biocompatibility, low
toxicity (Kamat et al., 2016). Chitosan has adhesive character the advantage that make
them promising and wound healing agents this is beside their antibacterial and
antifungal effect (Katas et al. 2013; Wang et al., 2011). Chitosan nanoparticles (ChNP)
are synthesized using non-toxic solvents as they are soluble in acidic medium
(Agnihotri et al., 2004). It was found that ChNP have higher antibacterial activity than
chitosan and chitin. This is due to the spherical character of NP, and the positive charge
of ChNP interact with the negatively charged surface of bacteria resulting in membrane
disruption, leakage of intracellular components and cell death (Divya et al., 2017). All
these benefits make them promising nanocarrier for drug delivery (Prabaharan, 2015).
Chitosan nanoparticles were loaded on calcium alginate hydrogel to reduce
inflammation and improve neovascularization (T. Wang et al., 2017), and were
incorporated in polycaprolactone nanofibers to improve wound healing (Jung et al.,
2015).
From our point of view, the only limitation of nanomaterials either nanofibers
or nanoparticles is the difficulty of large-scale commercial production. More research
is needed to move nanomaterials for wound healing from laboratory to the market
(Zafar et al., 2016; Chen et al., 2017).
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Figure 9 Mechanisms of Nanoparticle penetration through skin
Based on particle size, charge, morphology and polymer type, nanoparticles can
penetrate skin through the 1) Appendageal route, as hair follicles, sweat glands. 2)
Intracellular route through corneocytes 3) Intercellular route were particles pass
between corneocytes. Adapted from (Palmer et al., 2016).

1.8 Wound healing Models
Wound healing models are essential to study the pathogenesis of wound healing and to
identify molecular targets, as well as, to test new therapeutic approaches (Sami et al.,
2019; Ud-Din & Bayat, 2017). Wound models can be designed in silico, in vitro, ex
vivo and in vivo using computational, cell culture, wound biopsies, and animal models
(Wilhelm et al., 2017; Andrade et al., 2015; O’Dea et al., 2012). In vitro models are
used to test new drugs, and scaffolds but do not provide a clear view of the biological
interactions in a living organism, as they lack innervation and circulation that play
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critical role in the healing process (Andrade et al., 2015; Wilhelm et al., 2017; Ud-Din
& Bayat, 2017).
In vivo models are the most efficient wound healing models. They can either be
human, small or large animals. Human model has the advantage of testing new drugs
in clinical trials, their disadvantages include; the difficulty to obtain patients with
chronic wounds and the lack of uniformity of the wound type and microbial
composition (Ud-Din & Bayat, 2017). Animal models offer the best alternative. Large
animals such as pigs have great advantages, as they have skin type similar to the human
skin, and the main method of healing is through re-epithelization (Volk et al., 2013),
although some wound contraction occurs in some sites. The disadvantage of using pigs
is that they have significant high cost, and therefore hard to do replicates that provide
statistical significance (R. Perez et al., 2008).
Rodents are the most commonly used animals for wound healing models due to
their availability, low cost and small size, which makes it easy to include a relatively
large number of animals, which provides statistical significance and decreases error
(Trostrup et al., 2016). A great disadvantage of rodent use for chronic wounds is that
they have unique panniculus carnosus layer, which causes rapid wound contraction
(Wong et al., 2011), in addition to the significant differences in their immune systems
compared to humans, which limits the usefulness of these models (Seaton et al., 2015).
In the current study, we describe a new model that mimics chronic pressure ulcer
in human to address the shortcomings of other rodent wound models and overcome
wound contraction due to the panniculus carnosus muscle.
Infected and chronic wounds are difficult to treat especially in diabetic patients due
to bacterial resistance and excessive use of antibiotics. We describe a novel
combination of antibacterial agents from Turmeric/ Oregano/ Chitosan nanoparticles.

1.9 Hypothesis
We hypothesize that our designed formula will be non-cytotoxic, anti-inflammatory,
antioxidant, will clear wound infection, and improve wound healing, in diabetic animal
model.
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1.10 Objectives
Our objectives in the current study are;
1. Develop a deep pressure ulcer model in a diabetic animal and highlight the
difference between excisional wound and pressure ulcer healing process in
normal and diabetic animals.
2. Design

a

cost-effective

formulations

(ointment/amorphous

hydrogel/

Nanofibers), for chronic skin ulcers using turmeric, oregano and chitosan
nanoparticles.
3. In vitro and in vivo testing of the newly designed formulations, for cytotoxicity/
antibacterial, and wound healing efficacy.
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Chapter 2 : Materials & Methods
Materials
Streptozotocin (Sigma- Aldrich, USA). Ketamine and Xylazine Hydrochloride,
Ketoprofen, magnets (3 g weight, 15 mm diameter and 250 Gauss magnetic force).
Citric acid, Sodium citrate buffer (Al-Nasr Chemicals, Egypt), 5% glucose solution
(Al-Nasr Chemicals, Egypt). Chitosan Molecular weight 600,000 – 800,000 (Acros
Organics, Belgium), Tripolyphosphate (TPP; Mistral chemicals UK). Glucometer (Free
Style, Abbott, USA9), 99% acetic acid (Sigma- Aldrich, USA), Sodium Hydroxide (Al
Nasr Chemicals), Deionized water (DI), Turmeric ethanolic extract (Herb pharm,
USA), Turmeric CO2 Organic Oil Extract (plant Therapy, USA), and Oregano Essential
Oil (plant Therapy, USA), Difco Nutrient Broth, Difco Nutrient Agar (Thermo Fisher,
German), Staphylococcus aureus (S. aureus), Escherichia coli (E. coli), petrolatum
(Eva cosmetics), Polyvinyl Alcohol (PVA) “Mowiol 20-98” Mol. Wt = 125,000 (Sigma
Aldrich, Germany). Dulbecco’s Modified Eagles Media with L-glutamine (DMEM),
Alkaline Phosphate buffer (PBS), trypsin & Pen/Strep (Lonza, Belgium), Dimethyl
sulfoxide (DMSO; Sigma Aldrich), Acetic acid (Sigma Aldrich), Fetal Bovine Serum
(FBS) (Life Science group, UK), Thiazolyl blue tetrazolium bromide (MTT; Serva
Electrophores, Germany), Tegaderm patches (3M) FDA approved patches for diabetic
foot ulcers (U.S. FDA Resources).

Methods
2.1

Development of Pressure Ulcer in a Diabetic Animal Model

Animal handling: Male Sprague-Dawley rats weighing ≈150-200 grams, were housed
under standard 12 h light/ 12 h dark conditions with free access to water and food. All
procedures were performed in compliance with the national institute of health (NIH)
guidelines for the Care and Use of Laboratory Animals, and in compliance with the
guidelines established by the Institutional Animal Care and Use Committee (IACUC)
of the October University for Modern Sciences and Arts (MSA) ethical committee.
Rats were anesthetized with intraperitoneal (I.P) injection of ketamine/Xylazine
(ketamine 80-100 mg/kg, xylazine 10-12.5 mg/kg IP mg/kg), according to IACUC
guidelines. Hair was clipped and rat skin was cleaned using Betadine®. Rats were
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randomly divided into either control or experimental groups. The first group received
a full thickness excisional wound (12-15 mm2) extending through the panniculus
carnosus using surgical scissors. In second group a sterilized magnet (3 g weight, 15
mm diameter and 250 Gauss magnetic force) was inserted deep to the panniculus
carnosus muscle layer. An external magnet of the same dimensions was placed on the
skin surface. Both magnets were kept until necrosis of the sandwiched layer of skin and
both magnets fell producing an ulcer extending to the subcutaneous tissue.
A third group of animals were intraperitoneally injected with streptozocin (STZ) to
induce diabetes according to the method described by (Furman et al., 2015) with
modifications. After confirmation of diabetes, these animals also received a skin ulcer
using the method described above.
Macroscopic clinical assessment and photographs of the wounds were performed at the
time of surgery and on subsequent days. Wound evaluation using ImageJ® software
was performed at regular time intervals. Parameters such as; depth, granulation tissue,
and infection were assessed using scoring system adapted from (Martínez-De Jesús et
al., 2010; Perez et al., 2010; Y. Huang et al., 2015; Strauss et al., 2016), with
modifications. Each parameter received a score (zero= Healed, 1 minimal, 2 mild, 3
moderate, and 4 Severe).
Histopathological sections stained with hematoxylin and eosin (H&E) and masson
trichrome stain, slides were examined and photographed using a BX51 light microscope
(Olympus xc 30, Tokyo, Japan) and scored according to the scoring system originally
described by (Gal et al., 2008).

2.2 Chitosan Nanoparticles
2.2.1

Preparation of Chitosan solution

Chitosan solution of concentrations (0.05%, 0.1%, 0.2%, 0.3% (w/v)) were prepared
by stirring chitosan in an aqueous acetic acid solution (1% (v/v)) overnight at room
temperature. The pH of Chitosan solution was adjusted to 4.8 using 1 N NaOH (Kheiri
et al., 2017).
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2.2.2 Preparation of Chitosan Nanoparticles
Chitosan nanoparticles were prepared through ionotropic gelation as described by
(Calvo et al.,1997). Briefly, tripolyphosphate (TPP) solution of concentration 1 mg/ml
was added dropwise to chitosan solution at ratio TPP : Chitosan (1:3) under vigorous
magnetic stirring at room temperature 900 rpm for 30 minutes (Kheiri et al., 2017).
Opalescent solution was formed as indicator for nanoparticles formation. Nanoparticles
were collected by centrifugation (Eppendorf 5804 R) for two hours at speed 11,000 rpm
and temperature 4oC. Supernatants were discarded, and the particles were washed twice
with deionized water and centrifuged for 15 minutes in each cycle. Nanoparticles (NPs)
were finally re-dispersed in deionized water. Particles were kept in ice and sonicated
for 3 minutes using probe sonicator (Branson Sonifier 150). Finally, particles were
lyophilized (Biobase BK-FD10S ) and stored at -20oC for further use.
2.2.3 Nanoparticles Characterization
2.2.3.1 Hydrodynamic Size, Zeta Potential & Polydispersity Index
Nanoparticles (NPs) suspension was diluted with de-ionized (DI) water to a
concentration 1 mg/ml before analysis. The hydrodynamic diameter (HD) and zeta
potential (ZP), polydispersity index (PDI) were measured using a Malvern Zetasizer
Nano ZS90 (Malvern Instruments Ltd, UK). All samples were analyzed in triplicates at
25°C and results were expressed as mean ± standard deviation.
2.2.3.2 Morphological Assessment
Primary morphological analysis was performed visually using inverted light
microscope (Olympus 1X70).
For advanced nanoparticles morphological analysis, a diluted drop of NP
suspension (2 mg/ml) was spread on a glass slide and allowed to dry overnight at
room temperature. Prior to imaging samples were coated with a fine gold layer
using a gold sputter module for 90 seconds at 10 KV (JEOL JFC-1600 Auto fine
coater, Japan). Samples were examined using scanning electron microscopy (SEM:
FESEM, Leo Supra 55, Zeiss Inc., Oberkochen, Germany).
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2.3 Antibacterial Test
Serial dilutions were used to evaluate the antibacterial activity of the chitosan
nanoparticles & herbal extracts (turmeric ethanolic extract, turmeric CO2 organic oil
extract, and oregano essential oil), against gram positive and gram-negative bacterial
strains, Staphylococcus aureus and Escherichia coli respectively. The concentration of
chitosan nanoparticles tested were 5 mg/ml (0.5%), 10 mg/ml (1%), while the
concentrations of extracts used were 0.1%, 0.5%, 1%, 5% & 10% of each extract.
Each bacterial strain was added to nutrient broth and kept overnight in shaker incubator
(Innova 43). The optical density (OD) was adjusted to of 0.1 at wavelength of 625 nm
using spectrophotometer (Ultrospec 3100 pro). Extracts and nanoparticles were
sterilized under UV for 1.5 hours, samples were added to bacteria and incubated in
shaker incubator overnight (Innova 43). The samples as well as the controls were
serially diluted and spread on nutrient agar, which were then incubated overnight at
37oC. The experiment was performed three times in triplicates & the surviving colonies
were counted and compared to the control. Results were expressed in % bacterial
reduction according to the below equation;
% bacterial reduction = (1-T/C) *100
Where T is cfu/mL of test sample and C is cfu/ml of control.

2.4 Anti -Oxidant Assay
3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) Assay
The concept of this test depends on the reduction of the yellow tetrazolium salt to the
purple crystals of formazan by antioxidant compounds (Muraina et al., 2009). Briefly;
Tegaderm®, oregano, turmeric essential oil, and turmeric ethanolic extracts, were
dissolved either in DMSO or DMEM to a final concentration of 1%, 5%, while chitosan
nanoparticles were suspended at concentrations of 0.5%, 1% and incubated at 37oC in
shaker incubator overnight. Herbal extracts and chitosan nanoparticles were placed in
96 well plate (Grenier Bio). 20 µl of 5 mg/ml of MTT was added to each well and the
plate was incubated for 3 h at 37°C. Media were removed and DMSO was added to
solubilize the formazan blue crystals. The optical absorbance was measured at 570 nm
using a plate reader (SPECTROstar Nano, BMG Labtech, Ortenberg, Germany).
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2.5 Ointment Formulation
Petrolatum was used as a vehicle to carry herbal extracts. Briefly; oregano, turmeric
ethanolic extracts were levigated with petrolatum to form an ointment, concentrations
were 1%, 5% respectively. Ointment preparation was stored at room temperature until
use.

2.6 In vivo Pilot study
A pilot study to assess healing efficacy of turmeric and oregano was performed on
pressure ulcer in diabetic and non-diabetic rats. Briefly, 5% turmeric ointment and 1%
of oregano ointment was applied once a week. Macroscopic examination and scoring
were done to determine their effect on the healing process. Parameters such as ulcer
area, depth, granulation and inflammation, granulation and infection were investigated
with the following scoring system originally described by Martínez-De Jesús, 2010,
and Gupta & Kumar, 2015, with modifications: 0 = Healed; 1= minimal; 2= mild; 3=
moderate; and 4= Severe.

2.7

Formulation Preparation

2.7.1 Ointment
Petrolatum was used as a vehicle to carry herbal extracts and chitosan nanoparticles.
Briefly, oregano, turmeric ethanolic extracts and chitosan nanoparticles were levigated
with petrolatum to form concentrations 1%, 5% and 1% of each item respectively.
2.7.2 Amorphous Hydrogel
Polyvinyl alcohol (PVA) of concentration 12% was prepared by dissolving PVA in
deionized water in the autoclave at temperature 121o C for 15 minutes. After cooling,
herbal extracts of oregano, turmeric and chitosan nanoparticles were added to reach
final concentrations of 1%, 5% and 1% respectively. The mixture was stirred at room
temperature for 1 hour. The solution was filled in syringes and stored at room
temperature for further use.
2.7.3 Hydrogel Sheet
The amorphous hydrogel was poured in a petri dish and physically cross-linked through
repeated cycles of freeze-thawing (He et al., 2018; Kamoun et al., 2015). The plate was
stored in -50o C overnight, followed by 8 cycles of freeze-thawing were applied (1 hour
freezing at -50o C followed by thawing at room temperature for 30 minutes).
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2.7.4 Xerogel
The hydrogel sheet was freeze dried (Biobase BK-FD10S ) for 10 hours to obtain
Xerogel (Niknia & Kadkhodaee, 2017).
2.7.5 Nanofibers preparation
Polyvinyl alcohol of concentration 12% was prepared by dissolving PVA in DI water
for 3 hours at temperature 90oC. After cooling, herbal extracts added to a final
concentration of turmeric 5%, chitosan nanoparticles 1% and oregano 1%, and stirred
for 1 hour at room temperature. The polymer was then finally electrospun by applying
voltage 14, 16 & 18 KV and flow rate 0.8 ml/hr, 1.1 ml/hr & spinning distance 12 cm,
needle diameter was 21G.

2.8

Nanofibers Characterization

The electrospun fibers were characterized morphologically using (SEM: FESEM, Leo
Supra 55, Zeiss Inc., Oberkochen, Germany). Prior to imaging, samples were coated
with fine gold layer using a gold sputter module for 90 seconds at 10 KV (JEOL JFC1600 Auto fine coater, Japan). The fibers were checked for beads & the average
nanofiber diameters were determined using ImageJâ software. For each of the
developed nanofibrous mats, 100 fibers were measured, and the average diameter was
calculated.

2.9

Antibacterial Test for the designed Formulas

The antibacterial activity of the preparations, using Tegaderm® as positive control was
evaluated against both gram positive and gram-negative bacterial strains,
Staphylococcus aureus and Escherichia coli respectively. Each strain was added to
nutrient broth and kept overnight in shaker incubator (Innova 43). The optical density
(OD) was adjusted to of 0.1 at wavelength of 625 nm using spectrophotometer
(Ultrospec 3100 pro). The preparations were sterilized in ultraviolet radiation (UV) for
1.5 hours and incubated in shaker incubator overnight with the bacterial strains. The
samples, as well as the controls were serially diluted and spread on nutrient agar which
were then incubated at overnight at 37oC. The experiment was performed in triplicates
and the surviving colonies were counted and compared to the controls. Results were
expressed in % bacterial reduction according to the following equation;
% bacterial reduction = (1-T/C) *100
Where T is cfu/mL of test sample and C is cfu/ml of control.
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2.10 In vitro Biocompatibility
2.10.1 Cytotoxicity
Effects of the prepared formulas on cell viability was evaluated on of L929 cell line
(ATCC®), using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide] assay. The assay depends on the concept of reduction the yellow tetrazolium
salt to the purple crystals of formazan, due to the effect of dehydrogenase enzymes that
are released by the mitochondria of the living and active cells (Patravale et al., 2012).
The number of viable cells present is directly proportional to the amount of purple
formazan crystals developed.
Briefly, the prepared forms (ointment, hydrogel, nanofibers) as well as Tegaderm®
(positive control) were sterilized by UV, and conditioned media were prepared by
soaking different weights (10 mg, 20 mg) of the preparation in DMEM, containing , 5
% antibiotic Pen-Strept and 10% FBS for one day in shaker incubator (Innova 43) at
37o C.
Cells were seeded in clear 96-well plates (Grenier Bio) at a density of 5,000 cells/well
and incubated 24 h to allow cell attachment. The conditioned media were filtered
through 0.2µm syringe filters and added to the cells. The cells were then incubated with
the conditioned medium of each formulation using Tegaderm® as positive control &
cells without any treatment as negative control for 24 hours. Following incubation, the
medium was removed and replaced with new one, MTT prepared according to
manufactures instructions (Serva Electrophores, Germany) was added and cells were
incubated for 3 h. Finally, the medium was removed and DMSO was added to dissolve
the formazan crystals. The absorbance was measured at 570 nm using a microplate
reader (SPECTROstar Nano, BMG Labtech, Ortenberg, Germany). The test was
repeated eight times in triplicates for each preparation. Cell viability (%) was calculated
based on the following equation:
!"#$%$&' #&() %= (Ab *&+,') 570 nm −.b b'&/0 570 nm) / (.b 12/(#2' 570 nm −.b 3'&/0
570 nm)×100

Where Ab sample is the sample absorbance, Ab blank is the absorbance of blank, Ab
control is the absorbance of the control.
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2.10.2 Cell Morphological Examination
Following incubation with treatment as described above, the cells morphology was
examined using inverted microscope (Olympus 1X70).

2.11 In vivo Testing for the designed Preparations
2.11.1 Macroscopic Examination
In vivo study was done to assess healing efficacy of the designed formulations on
diabetic pressure ulcer model (described previously) in comparison to Tegadermâ as
positive control. All formulations were applied once a week. Macroscopic (clinical)
examination was performed to evaluate wound healing.

2.11.2 Histological Examination
At days 10, and 15 of treatment, rats were euthanized with an overdose of pentobarbital
(Thiopental sodium) 75 mg/kg, IP, and skin samples collected and fixed in 10%
paraformaldehyde, paraffin embedded, and 5 µ sections were cut and stained with
hematoxylin and eosin to assess inflammatory cells and granulation tissue, collagen
deposition was assessed using masson trichrome staining (Olympus xc30. Tokyo.
Japan).
Semi-quantitative method was used to evaluate following histological processes and
structures: re-epithelization, polymorphonuclear leucocytes (PMNL), fibroblasts, new
vessels, and new collagen. Sections were evaluated according to the scale: 0, 1, 2, 3, 4.
Parameters for histological assessment were adapted from (Gal et al., 2008).
Table 2: The semi-quantitative evaluation of histological sections
(ST – Surrounding Tissue, i.e. tissue out of GT; DL – Demarcation Line; SCT –
Subcutaneous Tissue; GT – Granulation Tissue).
Scale

Epithelization

PMNL

Fibroblasts

New vessels

Collagen

0

Thickness of cut edges

absent

absent

Absent

absent

1

Migration of cells (< 50%)

mild ST

mild ST

mild-SCT

minimal-GT

2

Migration of cells (≥ 50%)

mild DL/GT

mild-GT

mild-GT

mild-GT

3

Bridging the excision

moderate DL/GT

moderate-GT

moderate-GT

moderate-GT

4

keratinization

marked DL/GT

marked-GT

marked-GT

marked-GT
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2.12

Statistical Analysis

The statistical analysis were done using GraphPad PRISM software version 8.02
(Graphpad Inc., San Diego, CA, USA). All data were expressed in mean ± standard
deviation. The tests used to test significance were multiple t- test, one way analysis of
variance test (ANOVA) & 2- way ANOVA. In all analysis, P-value < 0.05 was
considered statistically significant. Post hoc tests were done to confirm where
differences occurred between groups.
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Chapter 3 : Results & Discussion
3.1

Development of Pressure Ulcer in a Diabetic Animal Model

Based on our results, pressure ulcers showed significant differences compared to
excisional wounds. The produced ulcer using the magnet method was a full thickness
skin ulcer extending to the subcutaneous tissue, similar to an ulcer of the third degree
that develops in human.
The pressure ulcer produced showed impaired healing and high infection rates, as well
as the development of fibrous connective tissue that impairs the healing process. These
ulcers provide an excellent model to study chronic wound healing. In diabetic rats the
ulcers showed significant changes due to the diabetic pathological changes in the skin
as well as impairment of the healing process (Figure 10).
Our conclusion was, that the diabetic pressure ulcer model is very useful to study the
impaired healing process, and to study the effect of new therapeutics for chronic
wounds (DG Sami et al, submitted 2019).
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Figure 10 Graphical representation for Development Of Pressure Ulcer in Rodents
Rats were injected intraperitoneally with Streptozotocin. 1.) Diabetes was confirmed through A.I) Fasting Blood Glucose level as diabetic group
showed significant increase in blood glucose level if compared to the non-diabetic group that showed normal levels. A.II) On Body Weight
diabetic group showed significant reduction in body weight if compared to the non-diabetic group. B.) Hematoxylin & Eosin of Pancreas showed
destruction of islets of Langerhans in diabetic group while non-diabetic group showed normal islets 2.) Pressure Ulcer was developed through
implanting magnet below the panniculus carnosus muscle and another magnet was applied above the skin while the other side served as excisional
wound in both non-diabetic & diabetic groups. B.I) After a week both magnets fell leaving pressure ulcer. B.II) Masson Trichrome stain for
the necrotic skin (sandwiched skin between magnets) showed sloughing of epidermal layer and hyalinosis of dermal layer. 3.) Macroscopic
Assessment was done to compare between excisional wound & pressure ulcer in non-diabetic rats & Pressure ulcer in diabetic rats. Pressure Ulcer
showed impaired healing if compared to excisional wound that was completely healed by day 21. Diabetic Pressure Ulcer didn’t show healing by
day 21.4) Microscopic Examination of Skin Biopsies A.I) Hematoxylin & Eosin stain to assess degree of inflammation between groups. A.II)
Masson Trichrome stain to assess collagen formation between groups. (Adapted from DG Sami et al., 2019 submitted for Publication).

33

3.2
Chitosan Nanoparticles Characterization
3.2.1 Hydrodynamic Size, Zeta Potential & Polydispersity Index
The mean particle size for chitosan nanoparticles showed a significant increase with
increasing concentrations of chitosan from 0.1% to 0.3% (p-value < 0.0001) (Figure
11). At a concentration of 0.05 %, chitosan particle size was very high (around 5000
nm). This might be due to insufficient chitosan to react with TPP (results not displayed).
This is consistent with Liu & Gao et al. (2008), who reported that the size of chitosan
nanoparticles depends on different factors one of them was chitosan concentration.

Figure 11 Chitosan Nanoparticles hydrodynamic average size
There is significant increase in average particle size with increase chitosan
concentration from 0.1% to 0.3% (P-value < 0.0001; n= 3 in triplicates).

Zeta potential was measured to study the stability of particles. Particles with zeta
potential greater than (>|30| mV) were considered stable, as particles exert electric
repulsion to avoid its aggregation (Kheiri et al.,2017). In agreement with this concept,
our particles formed at concentrations 0.1%, 0.2% & 0.3% showed high zeta potential
suggesting their stability for longer period of time (Table 3).
Poly dispersity index (PDI) is an important parameter when assessing uniformity of
nanoparticles in solution, larger PDI values indicates larger size distribution & may
indicate also aggregation (Clayton et al., 2016). Samples with PDI less than 0.5 indicate
narrow size distribution & high homogeneity (Al-Qushawi et al., 2016). Our results
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showed that our samples are highly homogenous with PDI of 0.3 for concentrations
0.1%, 0.28 for concertation 0.2% & 0.26 for 0.3% (Table 3).
It is notable that the hydrodynamic diameter (Z-average) of the particles measured by
dynamic light scattering (DLS) is higher than the size estimated from microscopy
because of the high swelling capacity of chitosan. Therefore, microscopic evaluation
through scanning electron microscopy (SEM) or transmission electron microscopy
(TEM) is necessary to determine actual particle size and asses its morphology (Kheiri
et al.,2017).
Table 3: Effect of Chitosan Concentration on Hydrodynamic Size, Zeta Potential &
Polydispersity Index
Chitosan Conc.

0.1%

0.2%

0.3%

265 ±11

335 ±43

381 ±30

+51±3

+49±7

+54±2

0.3

0.28

0.26

Parameter
Z- average (nm)
Zeta Potential (mv)
PDI

According to literature, there is no specific particle size for skin penetration as
nanoparticles can penetrate skin through various mechanisms (Zhang et al., 2013).
Previous research showed that smaller particles showed more skin penetration
compared to large particle size that was trapped on the surface in inflamed skin model
(Try et al., 2016). Retinol encapsulated chitosan nanoparticles of sizes ranges from 50200 nm were used for treatment of skin wrinkles, acne (Kim et al., 2006). Also,
chitosan encapsulating acyclovir with average size 350-700 nm for treatment of herpes
was tested in vitro (Hasanovic et al., 2009). Chitosan nanoparticles with small particle
size showed more antibacterial activity than large ones, due to increase in the surface
areas which would be in direct contact with the bacteria (Katas et al., 2011).
Based on this data and results of hydrodynamic size, we selected chitosan nanoparticles
formed at concentration 0.1% as they showed least particle size and stability (zeta
potential) for further testing (Figure 12).
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Figure 12 0.1 % Chitosan Nanoparticles average size, PDI & stability.
Average Particle size distribution of 0.1% chitosan nanoparticles was 255 nm, in
homogenous (monodisperse) solution PDI 0.2. B) The results showed particles of
high stability with zeta potential (+51 mv).

3.2.2 Morphology Characterization
Morphology of nanoparticles under inverted microscope with average size 400-500 µm,
this size was not accurate as the particles were swollen (Figure 13). Therefore, further
assessment of morphology using SEM was important to give accurate insight about the
actual morphology, size & aggregates (Singh et al., 2016). SEM revealed spherical
uniform nanoparticles with average diameter 77 nm & almost no aggregates (Figure
14).
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Figure 13 Morphology of Chitosan nanoparticles under light microscope
(Magnification 100 X)
A) Rounded chitosan nanoparticles (Black arrows).

B) The average size of

nanoparticles under inverted microscope was 400-500 µm.

Figure 14 Morphology of Chitosan nanoparticles through SEM
A) Rounded chitosan nanoparticles of almost uniform size (Black arrows) with no
aggregates can be seen. B) The average size of nanoparticles through SEM showed
to be nearly 77 nm.
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3.3

Antibacterial Test

Oregano essential oil was found to be very potent against both gram positive and gramnegative bacteria at a concentration of 0.1%, it showed 100% bactericidal effect
(Figure 15, 16). This agrees with previous reports who found oregano to be powerful
at concentration less than 2% (Hammer et al., 1999). It was hypothesized that essential
oils of oregano cause disruption of bacterial cell membrane, blocking their enzyme
system & disrupt ion exchange leading to cell death (Sakkas et al., 2017).
Turmeric ethanolic extract, caused total bacterial inhibition at concentrations of 0.1%
against S. aureus, and 5% against E. coli. To exclude the effect of ethanol, turmeric oil
supercritical CO2 extract was used. Total inhibition of both S. aureus & E.coli at 5%
was observed (Figure 15, 16).

Turmeric exerts its antibacterial activity through disruption of bacterial membrane
(Tyagi et al., 2015). It was noted that E. coli were less sensitive to turmeric extracts
compared to S. aureus. This agrees with previous reports, that showed Gram negative
(E. coli) were less susceptible due to the presence of lipopolysaccharide in their outer
membrane (Th et al., 2010).
ChNP showed increase in bacterial inhibition with increasing concentration from 0.5%
to 1%. They were found to be more potent against gram positive rather than gram
negative (Figure 17). Divya et al., (2017) also reported that ChNP showed more
inhibition on S. aureus than E. coli.

38

A.

Control

0.1%

0.5%

1%

5%

10%

no

ega
Or

t
c
eri trac
m
x
r
Tu olic E
n
ha
Et
c
eri CO2
m
l
r
a
Tu ritic t
c
c
per tra
Su Ex

B.

Figure 15 Effect of Oregano, Turmeric Extracts against S. aureus
A. Oregano & turmeric extracts (ethanolic / supercritical CO2) showed
antibacterial effect against S. aureus at very low concentration (0.1%). B.
Graphical representation of the results expressed in % bacterial reduction
(P<0.0001 ; n = 3 in triplicates).
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Figure 16 Effect of Oregano, Turmeric Extracts against E. coli
A. Oregano showed antibacterial effect against E. coli at very low concentration
(0.1%). Turmeric ethanolic extract was more potent than turmeric oil, both
showed total bacterial inhibition at concentration 5%. B. Graphical
representation of the results expressed in % bacterial reduction (P<0.0001 ;
n=3 in triplicates).
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A.

0.5%

1%

E. coli
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Control

B.

Figure 17 Effect of Chitosan nanoparticles on Gram positive & Gram-Negative
Bacteria
A. Chitosan nanoparticles showed significant increase in antibacterial activity with
increased concentration from 0.5% to 1%, in both gram positive (S. aureus) and
gram negative (E. coli). Chitosan nanoparticles were found to be more effective
on Gram positive more than Gram negative bacteria (P<0.0001). B. Graphical
representation of the results expressed in % bacterial reduction (P<0.0001).
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3.4

Anti - Oxidant Assay

Oregano showed significant increased antioxidant activity with increasing the
concentration. This agreed with previous literature that proved that the antioxidant
effect of oregano was due to the presence of the high phenolic content (Chun et al.2005;
Stanojević et al., 2018). Turmeric ethanolic extract showed more antioxidant power
than that of turmeric extracted by supercritical CO2 (p-value < 0.0001). This suggests
that the curcumin and the phenolic content might be higher in the ethanolic extracts.
This hypothesis agreed with previous reports that ethanol extraction enhanced phenol
and curcumin extraction (Martinez-Correa et al., 2017). Chitosan NP did not show
significant antioxidant activity at different concentrations (Figure 18). This is in
agreement with previous reports that found free Chitosan NP did not exhibit antioxidant
effects. Only after encapsulation with Quercetin chitosan showed high antioxidant
effect through scavenging of 1,1-diphenyl-2-picryl-hydrazyl radical (DPPH) radical
(Y. Zhang et al., 2008).
When the herbal extracts were suspended in DMEM media, significant increase in MTT
reduction was observed (P-value < 0.0001). This can be due to the interaction between
the phenolic groups in the extracts with the nutrients in the media that enhanced the
MTT reduction to give its formazan blue color (Figure 18). Previous study showed that
flavonoids in media influenced MTT reduction in the absence of cells (Talorete et al.,
2006).
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Figure 18 Antioxidant Effect of Herbs, ChNPs
Oregano showed significant increase in antioxidant activity with increase in the
concentration. Turmeric ethanolic extract 5% was more potent than turmeric
supercritical CO2 extract (P -value < 0.0001). Turmeric ethanolic extract 5% was more
potent than turmeric ethanolic extract 1% (P -value < 0.0001). ChNPs showed no
significant antioxidant activity. Media enhanced MTT reduction in the presence of
phenolic compounds of the herbs (P-value < 0.0001).
From the results of the antibacterial and antioxidant assays, we decided to use
oregano at concentration of 1%, turmeric ethanolic extract at a concentration of
5% & ChNPs at a concentration 1%.
Upon testing the above combination for their antioxidant activity against Tegaderm®
wound dressings. We found that our combination showed significant anti-oxidant
activity if compared to Tegaderm® that did not show any antioxidant power (P-value <
0.0001) (Figure 19). Oregano and turmeric extracts are rich in phenolic compounds
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that have great effect as antioxidants (Bordoloi et al., 2016; Nakatani et al., 2000).
Tegaderm® is calcium alginate dressing with silver. To date there is no test to assess its
antioxidant activity. Our results reveal that Tegaderm® has no antioxidant effect. This
can be due to the fact that silver act as strong oxidizing agent so, it didn’t affect MTT
(Syper et al, 1967 ; Pubchem).

Figure 19 Antioxidant Effect of Combination
Combination of 1% oregano, 5% turmeric ethanolic extract & 1% ChNP showed
significant antioxidant activity if compared to Tegaderm® that didn’t have any oxidant
power (P-value < 0.0001).
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3.5
In vivo Testing
3.5.1 Pilot study for Herbs Macroscopic Evaluation
Turmeric ointments (5%) showed improvement in the pressure ulcer healing process in
both diabetic and non-diabetic rats. Granulation tissue was greatly enhanced with
complete healing achieved by day 10 in non-diabetic rats, while complete healing was
achieved by day 15 in diabetic rats.
Although oregano 0.1% showed great antibacterial effect in vitro on both gram positive
and gram-negative bacteria, this concentration was not effective as an antiinflammatory on wounds. Therefore, the concentration was increased to 1% only to
avoid irritation. This concentration was found to be potent anti-bacterial In vivo. It also
dramatically improved granulation tissue formation with complete closure of the ulcer
achieved by day 15 in non-diabetic animals, while in the diabetic rats healing was
achieved by day 21 (Figure 20).
One previous study showed the effect of using 3% oregano ointment for wound healing
in patients with surgical excision. The study revealed significant reduction in bacterial
infection on post-surgical wounds and improved the scar appearance compared to
petrolatum (Ragi et al., 2011).
Turmeric extract 5 % ointment showed significant improvement in granulation and
decreased infection, compared to no treatment groups in both diabetic and non-diabetic
animals, achieving full wound closure by day 15 (Figure 20). Many researchers used
curcumin to asses wound healing, a recent study showed that ointment containing 5%
& 10% curcumin ethanolic extracts showed improved wound healing against an aspirin
retarded wound healing process (Pawar et al., 2015). Other studies showed that
curcumin applied in pluronic F127 gel, accelerated wound closure in mice (Yen et al.,
2018). Petrolatum containing 5% turmeric ethanolic extracts enhanced healing at the
episiotomy incision site in primiparous women. It decreased the period of healing from
14 days to10 days (Tara et al.,2009).
Our findings showed that, both oregano 1% and turmeric 5% ointments had advanced
reduction in the healing time, and improved granulation & decreased infection in both
diabetic and non-diabetic rats. However, oregano scored better in clearing infection
compared to turmeric. On the other hand, turmeric enhanced the granulation tissue
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formation more than oregano (Figure 21). To date, there is no comparative study
conducted between oregano and turmeric to assess their healing activity.
Recent studies showed that chitosan nanoparticle loaded calcium alginate hydrogel
demonstrated significant antibacterial activity & accelerated wound healing in vivo (T.
Wang et al., 2018).
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Figure 20 Photographic images to the extent of wound healing activity of Herbal
extracts.
Untreated group, the diabetic group showed higher infection rates, more crusty and
poor wound healing compared to the non-diabetic group. Turmeric treatment group
showed complete healing by day 15 in both non-diabetic & diabetic groups. Oregano
treatment group showed low infection, with complete healing by day 15 in non-diabetic
group and day 21 in the diabetic group.
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Figure 21 Effect of Herbs on Pressure Ulcer in Non-Diabetic and Diabetic Rats
Both 5% Turmeric & 1% Oregano reduced ulcer area in both models compared to the control group (No treatment). Turmeric 5 % had effect on
granulation tissue macroscopically compared to the control group (No treatment). Oregano 1 % reduced infection macroscopically compared to
the control group (No treatment).
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3.6

Preparation Selection

The formulas that were selected for further studies were the ointment, amorphous
hydrogel & nanofibers. The hydrogel sheet & xerogel were excluded from the study.
The hydrogel sheet was tested in vivo and it created a dry tough layer that impaired the
healing process (results not shown) (parhi et al, 2017; Kumar & Han, 2017). After the
hydrogel sheet was dried through lyophilization to form xerogel, the product shrank,
became very dry & lost its elasticity. Previous studies showed that upon PVA
lyophilization deformation happened, collapse of the pores which affect negatively cell
growth, therefore, limiting the use of xerogels (Yabin Zhang et al., 2015; Annabi et al.,
2010).

3.7

Nanofibers Characterization

Based on the results of SEM, we chose to work with flow rate 0.8 ml/ hr as higher flow
rates showed formation of beads (Figure 22). According to the literature, lower flow
rates were more suitable as the solvent will have enough time for evaporation (Annabi
et al., 2010). On analyzing the average fiber diameter of different voltages using
ImageJâ software, we decided to use 18KV, as it showed high frequency distribution
of narrow fiber diameters & the fiber diameter mean was 211 nm (Figure 23). This can
be attributed to the high level of jet stretching in relationship to increased charge
repulsion within the jet and a strong external electric field (Pillay et al., 2013).
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Figure 22 Effect of Flow rate on fiber Morphology
High flow rate 1.1 ml/hr resulted in the formation of beads (arrow), unlike the lower rate 0.8 ml/hr (red box) that produced uniform smooth
fibers.
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Figure 23 Effect of Different Voltages on fiber diameter distribution
Higher voltage (18 KV) resulted in increase in the frequency distribution of the narrow fiber diameter (average Diameter= 211± 115 nm) (red box).
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3.8

Antibacterial Test for the designed Formulations

According to the antibacterial results, our formulations in ointment, hydrogel &
nanofibers showed significant antibacterial effect on both gram positive & gramnegative bacteria (P-value < 0.0001). They showed antibacterial activity the same as
the positive control (Tegadermâ). Although nanofibers had antibacterial effect, it was
lower than that of the ointment & hydrogel (Figure 24). This can be due to the sustained
release the nanofibers provide for the incorporated extracts (Weng & Xie, 2015).
Another hypothesis is that electrospinning decreased the efficacy due to the volatility
of the herb extracts. In agreement with previous studies, free petrolatum and free PVA
did not show any antibacterial effect on both strains (Kawai & Hu, 2009; Hu & Wang,
2016; Gemeda et al., 2018).

Figure 24 Effect of different forms on Gram Positive and Gram-Negative Bacteria
A. Bacterial Panel: Treatment ointment, hydrogel showed significant reduction on
both S. aureus & E. coli as Tegaderm (positive control). Nanofibers also showed
significant bacterial reduction in both strains but less than the ointment & hydrogel.
Pure petrolatum & PVA didn’t show any antibacterial effect. B. Graphical
representation for the results (*P-value < 0.0001 ; n=3 in triplicates).
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3.9
In Vitro Biocompatibility
3.9.1 Cytotoxicity
Cell viability (MTT) assay of L929 cells was performed to assess the cytotoxicity of
the preparations on fibroblast cell line. Tegaderm® was used as a positive control, and
cells without any treatment as negative control (Figure 25). Quantitative determination
by MTT method showed that ointment, and hydrogel were not cytotoxic, the two
formulations led to a significant cell viability increase compared with viability of the
no treatment cells (negative control) (p-value < 0.0001). Tegadermâ was significantly
toxic causing 90% cell death (p-value < 0.0001). The high cytotoxic effect of
Tegadermâ could be attributed to the silver that the dressing contains. Previous studies
showed that silver based dressing exhibited significant cytotoxic effects on both
cultured keratinocytes and fibroblasts (Burd et al., 2007; Hiro et al., 2012).
Nanofibers, on the other hand showed almost 50% reduction in cell survival rate in a
concentration dependent manner (p-value < 0.05) (Figure 25).The significant reduction
in cell viability of nanofibers compared to the ointment, and hydrogel (p-value <
0.0001) can be attributed to reduction of particle size to nanoscale, which makes them
more cytotoxic than microscale particles (Bhattacharya et al., 2012;Sahu et al., 2016).
According to literature, the reduction in particle size leads to increase in the surface
area which makes the number of molecules more exposed and thus show high
reactivity. As a result, Reactive Oxygen Species (ROS) are produced which cause
oxidative stress, inflammation and consequently result in DNA and protein damage
(Khalili Fard et al., 2015).
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Figure 25 Effect of Different treatment forms on L929 cell Viability
Tegaderm treated cells (+ve control) showed significant reduction in cell viability if
compared to untreated cells (P-Value < 0.0001). Both ointment and hydrogels showed
significant increase in cell viability if compared to untreated cells (P-Value < 0.0001).
All formulations had significant better viability than Tegaderm treated cells (P-Value
< 0.0001). Nanofibers showed significant reduction in cell viability compared to the
negative control (P-Value < 0.0001). Nanofibers showed significant reduction in cell
viability in concentration dependent manner (P-Value < 0.05; n=8 in triplicates).
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3.9.2 Cell Morphology
Microscopic examination of the L929 cell cells under microscope 24 hrs post-treatment,
showed significant changes in cell morphology. Untreated cells (negative control)
showed a majority of spindle shaped cells adherent to the culture plate (Figure 26.A).
Tegaderm treated cells appeared rounded, and shrunken cells with no proliferation
(Figure 26.B). Ointment and hydrogel treated cells at different concentrations showed
normal spindle shaped cells with increased proliferation (Figure 26.C-F). Nanofiber
(10 mg/ml) treated cells showed changes in the morphology, with some cells appeared
rounded with reduced proliferation (Figure 26.G). Nanofiber (20 mg/ml) treated cells
showed severe changes and most cells appeared rounded and shrunken with reduction
in proliferation (Figure 26.H). Results of cell morphological assessment agree with
cell viability MTT assay results.
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Figure 26 Effect of Different treatment forms on mouse Fibroblast (L929) cell line
Morphology of fibroblast cell line (L929) after 24 hours
A) Control culture (-ve control) showed spindle shaped & rounded cells (arrow); B) Cells treated with Tegaderm (+ve control) showed rounded
damaged cells (arrow); Cells treated with ointment combination (10 mg/ml) (C) and (20 mg/ml) (D) showed normal cell morphology; Cells
treated with Hydrogel combination (10 mg/ml) (E) and (20 mg/ml) (F) showed normal cell morphology; Cells treated with Nanofibers (10
mg/ml) (G) showed altered cell morphology (arrow); while those treated with Nanofibers (20 mg/ml) showed rounded cells (H, arrow).
(Magnification X200) (n=8 in triplicates)
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3.10 In Vivo Testing for the designed Formulations
3.10.1 Macroscopic Examination
Macroscopic (clinical) assessment of pressure ulcer in diabetic rats, showed that
Tegaderm® caused poor healing and high infection compared to the other groups tested,
by day 21 the ulcer size was relatively smaller compared to the control (Figure 27).
Previous studies, showed that silver containing dressing prevented fibroblast
proliferation, which impaired wound healing (Burd et al., 2007). Our in vitro
assessment also supported this finding (Figure 26.B).
Amorphous hydrogel, according to some authors encourages autolytic debridement of
necrotic tissue. They work through rehydrating hard eschar and slough tissue and thus
promote the healing process (Dabiri et al., 2016). Our current results showed the
opposite, animal group treated with hydrogel showed a high rate of infection, very poor
healing and by day 21 the wound area was almost similar to that of the control group
(Figure 27). This can be attributed to the high-water content in the hydrogel, that made
it rich environment for growth of bacteria. Recent studies showed that amorphous
hydrogels exhibit poor bacterial barrier (Kamoun et al, 2017).
Animals treated with either ointment or Nanofibers showed very good healing, and low
infection, compared to the control, complete wound closure occurred by day 15 while
the untreated group till day 21 didn’t show complete healing (Figure 27).
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Figure 27 Macroscopic Assessment for the effect of Different Treatment forms on
Diabetic Pressure Ulcer
Control group (no treatment) showed high infection, high fibrous connective tissue, and
no healing by day 21. Tegaderm (+ ve control) and hydrogel treated rats showed poor
healing and high infection. By day 21 Tegaderm treated rats showed smaller wound
area compared to the no treatment group. Animals treated with ointment and those
treated with nanofibers showed complete healing by day 15 (n= 4-6).
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3.10.2 Histological Examination
10 Days following treatment, ointment & nanofibers treated groups showed migration
of basal epithelial cells (Figure 28. C, E). While untreated group, Tegaderm® treated
group and hydrogel treated group showed thickening of epidermal layer with necrotic
tissue (Figure 28. A, B, D). Masson trichrome staining showed moderate mature
collagen formation in ointment & nanofibers treated groups if compared to other groups
(Figure 29 C, E).
At day 15 following treatment, histological evaluation of the treatment groups showed
that in the no treatment (-ve control) group, the gap was covered by thick layer of
necrotic tissue, and inflammatory cell infiltration was evident. The dermal layer showed
new blood vessel formation (angiogenesis) and fibroblast proliferation that produced
moderate pattern of granulation tissue (Figure 28.F). Masson’s trichrome stained
section showed moderate mature collagen fibers (Figure 29.F).
Tegaderm treated group (+ ve control), showed a gap covered by a thick layer of
necrotic tissue. Inflammatory cells infiltration was seen as focal aggregation in
epidermal and dermal layers. The dermal layer showed new blood vessel formation
(angiogenesis) and fibroblast proliferation to produce moderate pattern of granulation
tissue (Figure 28.G). Masson’s trichrome stained tissue section showed moderate
mature collagen fibers (Figure 29.G).
In the ointment treatment group, the gap was covered by keratinization epithelial cell
layer with fewer numbers of inflammatory cells infiltrating mainly macrophages. The
dermal layer showed new blood vessel formation and fibroblast proliferation to produce
moderate pattern of granulation tissue (Figure 28.H). Masson’s trichrome stained
tissue section showed marked mature collagen fibers (Figure 29.H).
Hydrogel treatment group showed a gap with thickening of epidermis by necrotic
tissues at its cut edges with mild inflammatory cells infiltration mainly macrophages.
The dermal layer showed angiogenesis and fibroblast proliferation to produce marked
pattern of granulation tissue (Figure 28.I). Masson’s trichrome stained tissue section
showed marked mature collagen fibers score (Figure 29.I).
Nanofibers treatment showed a gap covered by non-keratinization epithelial layer
with few numbers of inflammatory cells infiltration mainly macrophages. The dermal
layer showed angiogenesis and fibroblast proliferation producing a moderate pattern of
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granulation tissue (Figure 28.J). Masson’s trichrome stained tissue section showed
marked mature collagen fibers score (Figure 29.J).
According to histological scoring results at day 15, ointment and nanofibers showed
best results compared to the negative and positive control. Better scores went to the
ointment as it showed keratinization, low infection and decreased angiogenesis which
were signs of complete healing (Table 4). This can be due to the rapid release of the
herbal extracts and chitosan nanoparticles from the ointment, while nanofibers provide
a slower sustained release. A previous study showed that, the release of vitamin-loaded
as-spun fiber mats showed gradual release over the test periods, while the
corresponding cast films exhibited a burst release of the vitamins (Taepaiboon et al.,
2007).
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Tegaderm
(+ve Control)

Ointment

Hydrogel

Nanofibers

Day 15

Day 10

No Treatment
(-ve Control)

Figure 28 Effects of Different treatment forms on Diabetic Pressure Ulcer (H&E)
10 Days post treatment the no treatment diabetic ulcer skin tissue sections (A) showed thickening of epidermis by necrotic tissues (arrow). Tegaderm treated group
(B) showed angiogenesis accompanied with fibrin thrombi (arrow). Ointment treated group showed (C) bridging of ulcer by epithelial cells (arrow). The Hydrogel
treatment group (D) showed necrotic tissues at its cut edges (arrow). The Nanofibers treatment Group (E) showed migration of basal epithelial cells (< 50%), (arrow).

15 Days post treatment the no treatment diabetic ulcer (F) showed moderate pattern of granulation tissue (arrow). The Tegaderm treated group (G) showed focal
aggregation of Inflammatory cells (arrow). Ointment treated group (H) showed keratinization epithelial cell layer (arrow). Hydrogel treatment (I) showed mild
inflammatory cells infiltration (arrow). And the Nanofibers treated Group (J) showed non-keratinization epithelial layer (arrow). Magnification (X 200) (n=4-6).
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Tegaderm
(+ve Control)

Ointment

Hydrogel

Nanofibers

Day 15

Day 10

No Treatment
(-ve Control)

Figure 29 Effects of Different treatment forms on Diabetic Pressure Ulcer using Masson Trichrome
10 Days post treatment, the no treatment diabetic ulcer (A) and hydrogel treatment group (D) showed minimal mature collagen fibers (arrow). While, the
Tegaderm treated group (B) showed mild mature collagen (arrow). Both ointment treated (C) and nanofibers treated (E) groups showed moderate mature collagen
fibers (arrows).

At Day 15 the no treatment diabetic ulcer (F) and the Tegaderm treated (G) groups showed moderate mature collagen fibers (arrows). While, the ointment treated
group (H) and the nanofibers treatment (J) showed marked mature collagen fibers (arrows). The hydrogel treatment group (I) also showed marked mature collagen
fibers (arrow). Magnification (X 200) (n=4-6).
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Table 4 Semi-quantitative Histological Scoring at Days 10, 15

Group/ Day
No Treatment (-ve Control)
Tegaderm (+ve Control)
Ointment
Hydrogel
Nanofiber

Epithelization
10
0
0
3
0
1

15
0
0
4
0
3

PMNL
10
4
4
2
4
2

15
3
3
1
2
1

Fibroblasts

New vessels

10
1
1
3
3
3

10
2
3
3
4
2

15
3
3
3
3
3

15
2
3
1
2
2

Collagen
10
1
3
3
2
4

15
3
3
4
3
4

Scoring results showed that ointment and nanofibers treatments had dramatic effect on
re-epithelization with the ointment showing better scores. The inflammatory infiltration
PMNL were greatly reduced in the ointment, and nanofibers treated groups compared
to the other groups. Angiogenesis was notably reduced in the ointment treated group
which indicates complete healing. All formulas; ointment, Nanofibers & hydrogel
enhanced collagen formation.
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Chapter 4 : Conclusion & Future Perspectives

In conclusion, bed sores & diabetic skin infections are considered burden to
healthcare & economies. In order to avoid excessive use of antibiotics and bacterial
resistance, natural herbs provide good alternative as antibacterial and wound healing
agents. From our results we found that turmeric, oregano extracts provide promising
antibacterial agents, possess anti-inflammatory effect and act as natural antioxidants.
The antibacterial and antioxidant tests showed that turmeric ethanolic extract
5%, oregano essential oil 1% & chitosan nanoparticles 1% had the most antibacterial
& antioxidant effects. Ointments were formulated of each herb individually. An in vivo
pilot study was conducted on diabetic and non-diabetic rats with pressure ulcer. Results
showed that turmeric 5% ointment successfully healed the ulcer in both diabetic and
non-diabetic rats by day 15. The oregano 1% ointment achieved complete healing by
day 15 in the non-diabetic group while in the diabetic group was achieved by day 21.
The above concentrations were incorporated in different forms (ointment,
amorphous hydrogel & nanofibers) and were tested in the current study in comparison
to commercially available wound dressing Tegadermâ (FDA approved dressing for
treatment of leg ulcers). The best formula was found to be ointment followed by
nanofibers. The prepared formulas showed significant antibacterial effects. On testing
the formulas on L929 mouse fibroblast cell lines, ointments and hydrogels were noncytotoxic and enhanced significantly cell proliferation. Nanofibers showed almost 50%
reduction in cell viability while Tegadermâ were significantly toxic (90%) to the cells.
In vivo results showed complete wound closure in 15 days, which suggest a great
potential for further clinical applications for these formulations in chronic wounds and
diabetic ulcers.
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Future Directions
Encapsulation of turmeric and oregano extracts in chitosan nanoparticles will
be of great value as they will provide sustained released for the extracts, protect them
for oxidation. This is beside that they will protect the volatile oils from being degraded
and as a result increasing their shelf life and retaining their function. Other advantage
of encapsulation can be overcoming the stain that turmeric causes which limits its
usage. Also, those formulated encapsulated nanoparticles can be embedded in spray
form or biodegradable wound dressings to provide protective effect to the ulcer beside
its healing effect.
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